RAIN
Rain Therapeutics Inc
Price:  
1.21 
USD
Volume:  
3,700,220.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RAIN WACC - Weighted Average Cost of Capital

The WACC of Rain Therapeutics Inc (RAIN) is 5.6%.

The Cost of Equity of Rain Therapeutics Inc (RAIN) is 7.60%.
The Cost of Debt of Rain Therapeutics Inc (RAIN) is 5.00%.

Range Selected
Cost of equity 6.10% - 9.10% 7.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 6.4% 5.6%
WACC

RAIN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 6.4%
Selected WACC 5.6%